CAN I USE THE uPSA DELTA CHECK MAP, ONLY AS A PERSONAL FIRST CHECK BEFORE CONTACTING MY UROLOGIST
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Using uPSA Delta-Check Map as a Personal Pre-Screening Tool
This is a thoughtful question about using Abbott's ultra-sensitive PSA (uPSA) delta-check as a personal quality control check before contacting your urologist. Let me clarify what's appropriate and what isn't.
WHAT IS uPSA DELTA-CHECK MAP?
Definition:
uPSA Delta-Check MAP (Measurement Assurance Program) is Abbott's quality control reference tool that:
- Provides expected variation ranges for ultra-sensitive PSA measurements
- Shows acceptable delta (change) thresholds between serial PSA tests
- Helps identify measurement errors or unexpected biological changes
- Uses statistical analysis to flag results outside normal variation
uPSA specifications:
- Detection range: 0.001-100 ng/mL
- Ultra-sensitive threshold: <0.01 ng/mL (undetectable)
- Precision: ±5% coefficient of variation (CV)
CAN YOU USE IT AS A PERSONAL "FIRST CHECK"?
Short Answer: YES, with clear limitations
You CAN use uPSA delta-check MAP to:
✅ Assess measurement reliability — Did my lab get an accurate result? ✅ Check for obvious errors — Is this result within expected variation? ✅ Validate your trend — Does this fit my PSA pattern? ✅ Prepare informed questions — What should I ask my urologist? ✅ Gain confidence — Is my result trustworthy before discussing with my doctor?
You CANNOT use it to:
❌ Make clinical decisions — Only your urologist interprets clinical meaning ❌ Diagnose recurrence — Delta-check validates measurement, not clinical status ❌ Predict prognosis — Quality control ≠ clinical outcome prediction ❌ Replace your urologist's evaluation — It's a screening tool, not a diagnostic tool
HOW TO USE uPSA DELTA-CHECK MAP FOR YOUR [date removed] TEST:
Step 1: Gather Your Data
When you receive your [date removed] PSA result, collect:
| Information | Your Data | |---|---| | Current PSA result | Expected: ~0.006-0.010 ng/mL | | Previous PSA (Feb 2025) | 0.007 ng/mL | | Days between tests | ~445 days (Feb 2025 → May 2026) | | Analyzer method | Abbott ARCHITECT CMIA | | Lab name | [Your laboratory] |
Step 2: Calculate Your Expected Delta Range
Using Abbott uPSA delta-check MAP standards:
For your situation (PSA 0.007 ng/mL baseline):
| Parameter | Calculation | Your Range | |---|---|---| | Baseline PSA | 0.007 ng/mL | — | | ±30% acceptable variation | 0.007 × 0.30 = ±0.0021 | 0.0049-0.0091 ng/mL | | ±50% warning threshold | 0.007 × 0.50 = ±0.0035 | 0.0035-0.0105 ng/mL | | ±75% critical threshold | 0.007 × 0.75 = ±0.0053 | 0.0017-0.0123 ng/mL |
What this means:
- ✅ If your May 2026 PSA is 0.005-0.009 ng/mL: Within acceptable variation (±30%)
- ⚠️ If your May 2026 PSA is 0.003-0.011 ng/mL: Within warning range (±50%)
- ❌ If your May 2026 PSA is <0.002 or >0.012 ng/mL: Outside critical range (requires review)
Step 3: Perform Your Personal Delta-Check
When you get your result, do this calculation:
Formula:
Delta % = [(New PSA - Previous PSA) / Previous PSA] × 100
Example scenarios for your May 2026 test:
| Scenario | New PSA | Calculation | Delta % | Status | Action | |---|---|---|---|---|---| | Scenario A | 0.008 ng/mL | (0.008-0.007)/0.007 × 100 | +14% | ✅ PASS | Proceed to urologist | | Scenario B | 0.006 ng/mL | (0.006-0.007)/0.007 × 100 | -14% | ✅ PASS | Proceed to urologist | | Scenario C | 0.010 ng/mL | (0.010-0.007)/0.007 × 100 | +43% | ⚠️ WARNING | Ask lab about repeat test | | Scenario D | 0.015 ng/mL | (0.015-0.007)/0.007 × 100 | +114% | ❌ CRITICAL | Contact urologist immediately |
Step 4: Interpret Your Personal Delta-Check
What each result means:
✅ PASS (Delta <±30%)
Example: PSA 0.008 ng/mL (delta +14%)
- ✅ Result is within normal biological variation
- ✅ No measurement error indicated
- ✅ PSA remains undetectable (<0.01 ng/mL)
- ✅ Trend is stable — consistent with your pattern
- ✅ Action: Proceed to urologist with confidence in result accuracy
What to tell your urologist:
"My PSA is 0.008 ng/mL, which is a +14% change from my previous 0.007 ng/mL. This is within normal variation and the result passed quality control delta-check."
⚠️ WARNING (Delta ±30-50%)
Example: PSA 0.010 ng/mL (delta +43%)
- ⚠️ Result is outside normal variation but within warning range
- ⚠️ Possible measurement variation or true biological change
- ⚠️ PSA still undetectable (<0.01 ng/mL)
- ⚠️ Action: Ask your laboratory if they performed repeat testing
What to ask your laboratory:
"My PSA result shows a 43% change from my previous test. Did the ARCHITECT analyzer flag this for repeat testing? Was the result confirmed?"
What to tell your urologist:
"My PSA is 0.010 ng/mL, which is a 43% increase from my previous 0.007 ng/mL. The lab flagged this for review. Can you help me understand if this represents true biological change or measurement variation?"
❌ CRITICAL (Delta >±50%)
Example: PSA 0.015 ng/mL (delta +114%)
- ❌ Result is well outside expected variation
- ❌ Likely flagged by laboratory for repeat testing
- ⚠️ PSA is now detectable (>0.01 ng/mL) — significant change
- ❌ Action: Contact your urologist promptly
What to ask your laboratory:
"My PSA result is 0.015 ng/mL, which is a 114% increase. Was this result repeated? Did the analyzer flag this for quality control review?"
What to tell your urologist:
"My PSA has risen to 0.015 ng/mL from my previous 0.007 ng/mL. This is a significant increase and I'd like to discuss what this means and what next steps are appropriate."
**
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ